Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
Do you have experience combining tocilizumab with mycophenolate in patients with scleroderma lung disease and inflammatory arthritis?
Related Questions
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
What is the maximum dose of leucovorin that you use with methotrexate?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
What is your typical steroid taper regimen for managing RA flares?
How do you help patients understand the difference between prolonged morning stiffness and pain?
How do you manage oral ulcers as a side effect from leflunomide?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
How would you manage a patient with severe deforming seronegative RA who has failed or been intolerant to DMARDs, TNFi, abatacept, Jak inhibitors, IL-6 and IL-1 agents in addition to Rituxan and moderate dose prednisone?
